Large damages payment looms for generic manufacturers in relation to Escitalopram

The Full Federal Court of Australia has dismissed an appeal by Alphapharm and others against the Federal Court decision to allow a patent term extension on Lundbeck’s patent covering the antidepressant drug Escitalopram (LEXAPRO) (the Escitalopram Patent) – Alphapharm Pty Ltd v H Lundbeck A/S [2015] FCAFC 138.   Background The patent at issue, Australian

The High Court confirms extensions of time for patent term extensions

The High Court of Australia has confirmed by a three to two majority that extensions of time under s223(2) of the Patents Act and the associated regulation permit the Commissioner of Patents to extend the time within which to apply for a pharmaceutical patent term extension under s70(1) – Alphapharm Pty Ltd v H Lundbeck